EMERGERS
Equity Research of
Nordic Growth Companies
Meny
EMERGERS
Equity Research of
Nordic Growth Companies
MODI reported Q2’24 sales largely in line with last year, at SEK 7.4m compared to SEK 7.6m in...
Supported by the latest troponin data generated from whole blood samples on the final commercial...
After initiating dosing of the first patient in June with Nanexa’s long-acting depot formulation...
While the commercialization of Crunchfish’s solution for offline payments has shown a longer...
In terms of financials, Q2 was largely a repeat of Q1, with one-off replanting and remediation...
The announcement of the updated DFS for Dannemora showed, as expected, higher CAPEX and OPEX...
Prolight’s report for Q1’24 did not reveal any particular surprises. The positive SEK 5.6m...
As announced already in February, capacity utilization and turnover in Q1 were weighed down by the...
